Torii Pharmaceutical to delist from Tokyo Stock Exchange Prime Market

Torii Pharmaceutical announced its shares will be delisted from the Tokyo Stock Exchange's Prime Market on August 28, 2025. This decision follows shareholder approval of a share consolidation proposal at an extraordinary general meeting held on August 8, 2025.

The company's common shares will no longer meet the listing criteria stipulated by the Tokyo Stock Exchange's listing rules for marketable securities, leading to the delisting. For further details, the company referred to its August 8, 2025, announcement regarding the approval of the share consolidation, the abolishment of the minimum trading unit, and partial amendments to the articles of incorporation.

Torii Pharmaceutical expressed deep gratitude to its shareholders and stakeholders for their long-standing understanding and support. The company affirmed its commitment to continue contributing to healthcare, supporting patients' health, and creating greater social value.